PierianDx announced today two key additions that will expand the organization’s reach into health systems and global markets while deepening clinical expertise. BG Jones has been named Senior Vice President of Business Development and will lead the expansion of PierianDx’s clinical genomics platform into health systems in the U.S. and global markets while cultivating partner […]
Harvard Bioscience, Inc. (Nasdaq:HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, appointed Katherine Eade and Thomas Loewald as Class II directors of the Board of Directors, effective as of October 24, 2017. Ms. Eade is Director, M&A Law and Transactions at Corning. Prior to […]
Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics researchers the right tool for the job, announced the appointment of Max Carnecchia to its Board today. Max is currently the Chief Executive Officer of Illuminate Education, which creates cloud delivered tools for educators that promote student success. Over 7 million K-12 students […]
WILSONVILLE, Ore. — FLIR Systems, Inc. (NASDAQ:FLIR) today announced that on October 19, 2017 Robert S. Tyrer was elected to its Board of Directors. The addition of Mr. Tyrer increases FLIR Systems’ Board of Directors to 11 members. FLIR Systems Announces Election of Robert S. Tyrer to Board of Directors Since 2001, Mr. Tyrer has been the Co-President of The Cohen Group, a business advisory firm […]
WILSONVILLE, Ore. — FLIR Systems, Inc. (NASDAQ:FLIR) today announced that Carol P. Lowe will join the company as Executive Vice President and Chief Financial Officer, effective November 27, 2017. Reporting to FLIR President and CEO Jim Cannon, Lowe will lead FLIR’s global finance organization with responsibility over all financial operations, including reporting, controls, planning, and strategy. Carol Lowe Named Executive Vice President and […]
As of today’s date the Board of Directors has resolved to submit for approval the following changes of representative director and officers to the General Shareholders, the Board of Directors, and the Audit & Supervisory Board Members meetings to be held on December 22, 2017. In an effort to strengthen the management and promote growth […]
MILFORD, Mass. — Waters Corporation (NYSE: WAT) announced today that Douglas A. Berthiaume will retire as Chairman of the Board of Directors of the Company, effective December 31, 2017. The Board of Directors has elected Christopher J. O’Connell, President and Chief Executive Officer, as its new Chairman effective January 1, 2018. Thomas P. Salice will continue to serve as the […]
Laboratory instrumentation standard-bearer announces plans for 20% growth, opening of regional sales and service hubs in Los Angeles and Houston. The company is also in the beginning stages of a full-scale hiring wave. ASHLAND, Va. Anton Paar, the premier manufacturer of laboratory instruments and process measurement systems, has announced an aggressive growth strategy for 2018, […]
Cambridge, Mass. – ReadCoor, Inc., a company reinventing omics and pathology with its panomic spatial sequencing platform, today announced the appointment of Thomas M. Grogan, M.D., to its Board of Directors. Dr. Gorgan is the renowned pathologist and founder of Ventana Medical Systems, a world leader and innovator of tissue-based diagnostic solutions for patients worldwide. “We are […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
